Development and validation of a nomogram for predicting bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary disease

Wang,Xiaoming; Yuan,Wanqiu; Zhong,Dian; Chen,Xiaolin

doi:10.3892/etm.2024.12753

Development and validation of a nomogram for predicting bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary disease

Authors:
- Xiaoming Wang
- Wanqiu Yuan
- Dian Zhong
- Xiaolin Chen
View Affiliations

Affiliations: Department of Laboratory Medicine, Pingxiang People's Hospital, Pingxiang, Jiangxi 337000, P.R. China, Department of Anesthesiology, Pingxiang People's Hospital, Pingxiang, Jiangxi 337000, P.R. China, Department of Respiratory and Critical Care Medicine, Pingxiang People's Hospital, Pingxiang, Jiangxi 337000, P.R. China
Published online on: October 24, 2024 https://doi.org/10.3892/etm.2024.12753
Article Number: 3
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bacterial infection is a significant contributory factor in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and it has a pivotal role in exacerbating symptoms and precipitating mortality among patients with chronic obstructive pulmonary disease (COPD). The early identification of bacterial infection in individuals with COPD remains a challenge. Therefore, the present study aimed to create and validate a risk assessment tool using easily accessible serum biomarkers to predict bacterial infection in individuals with AECOPD. A retrospective cohort study was carried out at Pingxiang People's Hospital (Pingxiang, China) from January 2023 to December 2023, involving individuals diagnosed with AECOPD. A total of 544 patients with AECOPD were randomly allocated to the two following groups: The training set, which included 70% (n=384) of the patients, and the validation set, which included 30% (n=160) of the patients. Subsequently, a nomogram model was constructed using multivariate logistic regression analysis in the training set. Its discriminatory ability and calibration were internally validated, while decision curve analyses were employed to assess the clinical utility of the nomogram. The incidence of bacterial infection in hospitalized patients with AECOPD was 50% in the training set and 48.1% in the validation set. The nomogram model incorporated independent factors associated with bacterial infection, including C‑reactive protein, neutrophil elastase, procalcitonin and eosinophils, identified by univariate and multivariate logistic regression analyses. The area under the curve of the nomogram model was 0.835 [95% confidence interval (CI): 0.795‑0.875] in the training set and 0.785 (95% CI: 0.715‑0.856) in the validation set. The model demonstrated excellent discrimination and calibration in the validation set [c‑statistic: 0.79 (95% CI: 0.68‑0.90)]. Furthermore, the discrimination and overfitting bias of the model were assessed through internal validation, revealing a C‑index of 0.836 for the initial group and 0.788 for the subsequent validation set. The straightforward risk prediction model for early identification of bacterial infections is valuable for hospitalized patients with AECOPD.

View Figures

View References

1	Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 187:347–365. 2013.PubMed/NCBI View Article : Google Scholar
2	Ouyang P, Zhou Z, Pan C, Tang P, Long S, Liao X, Liu Q and Xie L: Acute exacerbation of chronic obstructive pulmonary disease due to carbapenem-resistant klebsiella pneumoniae-induced pneumonia: Clinical features and prognostic factors. Int J Chron Obstruct Pulmon Dis. 19:683–693. 2024.PubMed/NCBI View Article : Google Scholar
3	Abi Abdallah G, Diop S, Jamme M, Legriel S and Ferre A: Respiratory infection triggering severe acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 19:555–565. 2024.PubMed/NCBI View Article : Google Scholar
4	Messous S, Elargoubi A, Pillet S, Rajoharison A, Hoffmann J, Trabelsi I, Grissa MH, Boukef R, Beltaief K, Mastouri M, et al: Bacterial and viral infection in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease: Implication for antimicrobial management and clinical outcome. COPD. 18:53–61. 2021.PubMed/NCBI View Article : Google Scholar
5	Martinez-Garcia MA, Faner R, Oscullo G, la Rosa-Carrillo D, Soler-Cataluna JJ, Ballester M, Muriel A and Agusti A: Chronic bronchial infection is associated with more rapid lung function decline in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 19:1842–1847. 2022.PubMed/NCBI View Article : Google Scholar
6	Martinez-Garcia MA and Alvar A: POINT: Is chronic bacterial infection clinically relevant in COPD? Yes. Chest. 162:970–972. 2022.PubMed/NCBI View Article : Google Scholar
7	Brennan M, McDonnell MJ, Harrison MJ, Duignan N, O'Regan A, Murphy DM, Ward C and Rutherford RM: Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): Beyond the guidelines. Respir Res. 23(58)2022.PubMed/NCBI View Article : Google Scholar
8	Moghoofei M, Azimzadeh Jamalkandi S, Moein M, Salimian J and Ahmadi A: Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis. Infection. 48:19–35. 2020.PubMed/NCBI View Article : Google Scholar
9	Smith D, Gill A, Hall L and Turner AM: Prevalence, pattern, risks factors and consequences of antibiotic resistance in COPD: A systematic review. COPD. 18:672–682. 2021.PubMed/NCBI View Article : Google Scholar
10	Pazmany P, Soos A, Hegyi P, Dohos D, Kiss S, Szakacs Z, Parniczky A, Garami A, Peterfi Z and Molnar Z: Inflammatory biomarkers are inaccurate indicators of bacterial infection on admission in patients with acute exacerbation of chronic obstructive pulmonary disease-A systematic review and diagnostic accuracy network meta-analysis. Front Med (Lausanne). 8(639794)2021.PubMed/NCBI View Article : Google Scholar
11	Qian Y, Cai C, Sun M, Lv D and Zhao Y: Analyses of factors associated with acute exacerbations of chronic obstructive pulmonary disease: A review. Int J Chron Obstruct Pulmon Dis. 18:2707–2723. 2023.PubMed/NCBI View Article : Google Scholar
12	Duan T: Analysis of microbiological and clinical characteristics of bacterial infection in patients with pulmonary infection. Comput Intell Neurosci. 2022(5607358)2022.PubMed/NCBI View Article : Google Scholar
13	Zhang Y, Zheng SP, Hou YF, Jie XY, Wang D, Da HJ, Li HX, He J, Zhao HY, Liu JH, et al: A predictive model for frequent exacerbator phenotype of acute exacerbations of chronic obstructive pulmonary disease. J Thorac Dis. 15:6502–6514. 2023.PubMed/NCBI View Article : Google Scholar
14	Thulborn SJ, Mistry V, Brightling CE, Moffitt KL, Ribeiro D and Bafadhel M: Neutrophil elastase as a biomarker for bacterial infection in COPD. Respir Res. 20(170)2019.PubMed/NCBI View Article : Google Scholar
15	Hoult G, Gillespie D, Wilkinson TMA, Thomas M and Francis NA: Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): A systematic review and meta-analysis. BMC Pulm Med. 22(194)2022.PubMed/NCBI View Article : Google Scholar
16	Zheng S, Kummarapurugu AB, Bulut GB, Syed A, Kang L and Voynow JA: Neutrophil elastase activates the release of extracellular traps from COPD blood monocyte-derived macrophages. Clin Transl Sci. 16:2765–2778. 2023.PubMed/NCBI View Article : Google Scholar
17	Boxio R, Wartelle J, Nawrocki-Raby B, Lagrange B, Malleret L, Hirche T, Taggart C, Pacheco Y, Devouassoux G and Bentaher A: Neutrophil elastase cleaves epithelial cadherin in acutely injured lung epithelium. Respir Res. 17(129)2016.PubMed/NCBI View Article : Google Scholar
18	Benjamin JT, Plosa EJ, Sucre JM, van der Meer R, Dave S, Gutor S, Nichols DS, Gulleman PM, Jetter CS, Han W, et al: Neutrophilic inflammation during lung development disrupts elastin assembly and predisposes adult mice to COPD. J Clin Invest. 131(e139481)2021.PubMed/NCBI View Article : Google Scholar
19	Park S, Lee SJ, Shin B, Lee SJ, Kim SH, Kwon WC, Kim J and Lee MK: The association of delta neutrophil index with the prognosis of acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med. 20(47)2020.PubMed/NCBI View Article : Google Scholar
20	Deng F, Zhong S, Yu C, Zhao H, Huang H, Meng X, Lin C and Cai S: Abnormal neutrophil polarization in chronic obstructive pulmonary disease and how cigarette smoke extracts attract neutrophils. Ann Transl Med. 10(472)2022.PubMed/NCBI View Article : Google Scholar
21	Gu L, Liu W, Huang JA, Zhu L, Hu X, Yue J and Lin J: The role of neutrophil counts, infections and smoking in mediating the effect of bronchiectasis on chronic obstructive pulmonary disease: A mendelian randomization study. BMC Pulm Med. 24(144)2024.PubMed/NCBI View Article : Google Scholar
22	Guan X, Yuan Y, Wang G, Zheng R, Zhang J, Dong B, Ran N, Hsu AC, Wang C and Wang F: Ginsenoside Rg3 ameliorates acute exacerbation of COPD by suppressing neutrophil migration. Int Immunopharmacol. 83(106449)2020.PubMed/NCBI View Article : Google Scholar
23	Choi J, Oh JY, Lee YS, Hur GY, Lee SY, Shim JJ, Kang KH and Min KH: The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 14:953–959. 2019.PubMed/NCBI View Article : Google Scholar
24	Thulborn SJ, Dilpazir M, Haldar K, Mistry V, Brightling CE, Barer MR and Bafadhel M: Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD. Int J Chron Obstruct Pulmon Dis. 12:1199–1205. 2017.PubMed/NCBI View Article : Google Scholar
25	Titova E, Christensen A, Henriksen AH, Steinshamn S and Asberg A: Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: A prospective observational study. Chron Respir Dis. 16(1479972318769762)2019.PubMed/NCBI View Article : Google Scholar
26	Daniels JM, Schoorl M, Snijders D, Knol DL, Lutter R, Jansen HM and Boersma WG: Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest. 138:1108–1115. 2010.PubMed/NCBI View Article : Google Scholar
27	An X, Zhang C, Weng X, Xiao W, Sun Z, Zeng Z and Huang Q: C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 99(e21152)2020.PubMed/NCBI View Article : Google Scholar
28	Mathioudakis AG, Chatzimavridou-Grigoriadou V, Corlateanu A and Vestbo J: Procalcitonin to guide antibiotic administration in COPD exacerbations: A meta-analysis. Eur Respir Rev. 26(160073)2017.PubMed/NCBI View Article : Google Scholar
29	Huang L, Wang J, Gu X, Sheng W, Wang Y and Cao B: Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: Study protocol for a multicenter randomised controlled trial. BMJ Open. 11(e049515)2021.PubMed/NCBI View Article : Google Scholar
30	Tang L, Shi S, Wang B, Liu L, Yang Y, Sun X, Ni Z and Wang X: Effect of urban air pollution on CRP and coagulation: A study on inpatients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med. 21(296)2021.PubMed/NCBI View Article : Google Scholar
31	Mou S, Zhang W, Deng Y, Tang Z and Jiang D: Comparison of CRP, procalcitonin, neutrophil counts, eosinophil counts, sTREM-1, and OPN between pneumonic and nonpneumonic exacerbations in COPD patients. Can Respir J. 2022(7609083)2022.PubMed/NCBI View Article : Google Scholar